-
-
-
-
-
-
-
InMed Pharmaceuticals Amends Preferred Investment Options
-
-
-
-
-
-
-
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
-
-
-
-
-
-
-
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Misses Q3 EPS by 194c
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Granted Patent for Novel Compounds
-
-
-
-
-
-
-
InMed Enters Into Standby Equity Purchase Agreement
-
410,650 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

